Pub Date : 2024-09-12DOI: 10.1016/j.joca.2024.09.003
Niko Sillanpää, Marika Iivanainen, Aleksandra Turkiewicz, Raine Sihvonen, Mika Paavola, Simo Taimela, Teppo L.N. Järvinen, Martin Englund
To assess the 5-year effects of arthroscopic partial meniscectomy (APM) vs. placebo surgery on the development of the structural changes of the knee by magnetic resonance imaging (MRI).
{"title":"Effect of arthroscopic partial meniscectomy on structural degeneration of the knee – A 5-year MRI-based follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial","authors":"Niko Sillanpää, Marika Iivanainen, Aleksandra Turkiewicz, Raine Sihvonen, Mika Paavola, Simo Taimela, Teppo L.N. Järvinen, Martin Englund","doi":"10.1016/j.joca.2024.09.003","DOIUrl":"https://doi.org/10.1016/j.joca.2024.09.003","url":null,"abstract":"To assess the 5-year effects of arthroscopic partial meniscectomy (APM) vs. placebo surgery on the development of the structural changes of the knee by magnetic resonance imaging (MRI).","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"13 1","pages":""},"PeriodicalIF":7.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12DOI: 10.1016/j.joca.2024.09.004
Aleksandra Turkiewicz, Clara Hellberg, Andrea Dell’Isola, Martin Englund
Antihistamines have been reported to be linked with less pain in osteoarthritis. We aimed to estimate associations between antihistamine use and three outcomes: prevalent osteoarthritis, current joint pain, and developing osteoarthritis.
{"title":"Antihistamine use and osteoarthritis or joint pain","authors":"Aleksandra Turkiewicz, Clara Hellberg, Andrea Dell’Isola, Martin Englund","doi":"10.1016/j.joca.2024.09.004","DOIUrl":"https://doi.org/10.1016/j.joca.2024.09.004","url":null,"abstract":"Antihistamines have been reported to be linked with less pain in osteoarthritis. We aimed to estimate associations between antihistamine use and three outcomes: prevalent osteoarthritis, current joint pain, and developing osteoarthritis.","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"12 1","pages":""},"PeriodicalIF":7.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12DOI: 10.1016/j.joca.2024.09.001
Rupsa Bhattacharjee , Eric Hammond , Ngarmsrikam Chotigar , Zehra Akkaya , Fei Jiang , Emma Bahroos , Misung Han , Spencer Behr , Matthew D. Bucknor , Richard B. Souza , Valentina Pedoia , Sharmila Majumdar
Objective
Loading is invariably an important factor of consideration for understanding the causality flow and parallel existence of articular cartilage and subchondral bone changes. The goal of this study was to investigate the patterns of subregional 18NaF-SUV vs. T1p-T2 associations and vertical ground reaction force loading rates; in isolated patellofemoral-joint-osteoarthritis (PFJ-OA) patients.
Method
Thirty-five isolated PFJ-OA patients, with no tibiofemoral involvement, underwent simultaneous scans in a 3.0T whole-body hybrid positron emission tomography–magnetic resonance imaging scanner. MRI Whole-Organ Magnetic Resonance Imaging Scoring assessments were performed to identify/confirm isolated PFJ-OA knees from bilateral scans. T1p-T2 relaxation and SUV values were automatically computed for both trochlear and patellar cartilage and subchondral bone subregions (deep, superficial, lateral, and medial). Maximum vertical impact loading rates (Loading-RateNorm) were calculated from walking trials. Relationships were explored between SUV uptake, T1p-T2 values, and Loading-RateNorm via linear mixed-effects modeling.
Results
Significant and complex association patterns were noted between medial and lateral bone 18NaF-SUV uptakes vs. medial and lateral cartilage sub-regional T1p and T2. SUVMean and SUVMax were positively associated with deep cartilage subregional T1pand T2 values; and negatively associated with superficial cartilage subregional T1p-T2 values in both medial and lateral regions. Both medial and lateral bone 18NaF-SUVMean and SUVMax uptakes remained positively associated with the individual gait characteristics, i.e., peak vertical impact loading rates (Loading-RateNorm).
Conclusion
Evidence of simultaneous, complementary, cross-sectional associations between T1p-T2 values and peak vertical loading rates with 18NaF-SUV, have been rare in the isolated PFJ-OA cohort. The clinical implications of such novel associations remain of utmost importance from a gait retraining perspective.
{"title":"The relationships between patellofemoral bone remodeling, cartilage composition, and vertical loading rate: PET/MRI in isolated patellofemoral osteoarthritis","authors":"Rupsa Bhattacharjee , Eric Hammond , Ngarmsrikam Chotigar , Zehra Akkaya , Fei Jiang , Emma Bahroos , Misung Han , Spencer Behr , Matthew D. Bucknor , Richard B. Souza , Valentina Pedoia , Sharmila Majumdar","doi":"10.1016/j.joca.2024.09.001","DOIUrl":"10.1016/j.joca.2024.09.001","url":null,"abstract":"<div><h3>Objective</h3><div>Loading is invariably an important factor of consideration for understanding the causality flow and parallel existence of articular cartilage and subchondral bone changes. The goal of this study was to investigate the patterns of subregional <sup>18</sup>NaF-SUV vs. T<sub>1<em>p</em></sub>-T<sub>2</sub> associations and vertical ground reaction force loading rates; in isolated patellofemoral-joint-osteoarthritis (PFJ-OA) patients.</div></div><div><h3>Method</h3><div>Thirty-five isolated PFJ-OA patients, with no tibiofemoral involvement, underwent simultaneous scans in a 3.0T whole-body hybrid positron emission tomography–magnetic resonance imaging scanner. MRI Whole-Organ Magnetic Resonance Imaging Scoring assessments were performed to identify/confirm isolated PFJ-OA knees from bilateral scans. T<sub>1<em>p</em></sub>-T<sub>2</sub> relaxation and SUV values were automatically computed for both trochlear and patellar cartilage and subchondral bone subregions (deep, superficial, lateral, and medial). Maximum vertical impact loading rates (Loading-Rate<sub>Norm</sub>) were calculated from walking trials. Relationships were explored between SUV uptake, T<sub>1<em>p</em></sub>-T<sub>2</sub> values, and Loading-Rate<sub>Norm</sub> via linear mixed-effects modeling.</div></div><div><h3>Results</h3><div>Significant and complex association patterns were noted between medial and lateral bone <sup>18</sup>NaF-SUV uptakes vs. medial and lateral cartilage sub-regional T<sub>1<em>p</em></sub> and T<sub>2</sub>. SUV<sub>Mean</sub> and SUV<sub>Max</sub> were positively associated with deep cartilage subregional T<sub>1<em>p</em></sub> <em>and</em> T<sub>2</sub> values; and negatively associated with superficial cartilage subregional T<sub>1<em>p</em></sub><em>-</em>T<sub>2</sub> values in both medial and lateral regions. Both medial and lateral bone <sup>18</sup>NaF-SUV<sub>Mean</sub> and SUV<sub>Max</sub> uptakes remained positively associated with the individual gait characteristics, i.e., peak vertical impact loading rates (Loading-Rate<sub>Norm</sub>).</div></div><div><h3>Conclusion</h3><div>Evidence of simultaneous, complementary, cross-sectional associations between T<sub>1<em>p</em></sub><em>-</em>T<sub>2</sub> values and peak vertical loading rates with <sup>18</sup>NaF-SUV, have been rare in the isolated PFJ-OA cohort. The clinical implications of such novel associations remain of utmost importance from a gait retraining perspective.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1591-1600"},"PeriodicalIF":7.2,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10DOI: 10.1016/j.joca.2024.08.014
Tiago V Pereira,Pakeezah Saadat,Pavlos Bobos,Samir M Iskander,Nicolas S Bodmer,Martina Rudnicki,Henry Dan Kiyomoto,Thais Montezuma,Matheus O Almeida,Rishi Bansal,Pai-Shan Cheng,Jason W Busse,Alex J Sutton,Peter Tugwell,Gillian A Hawker,Peter Jüni,Bruno R da Costa
OBJECTIVETo quantify the effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis through a systematic review and Bayesian random-effects network meta-analysis.DESIGNWe searched CENTRAL and regulatory agency websites (inception-2023) for large, English-language, randomised controlled trials (RCTs) (≥100 patients/group) examining any intra-articular intervention.PRIMARY OUTCOMEpain intensity.SECONDARY OUTCOMESphysical function and safety outcomes. Pain and function outcomes were analyzed at 2,6,12,24, and 52 weeks post-randomization, and presented as standardized mean differences (SMDs) (95% credible intervals, 95%CrI). The prespecified minimal clinically important between-group difference (MID) was -0.37 SMD. Safety outcomes were presented as odds ratios (OR) (95%CrI).FINDINGSAmong 57 RCTs (22,795 participants) examining 18 intra-articular interventions, usual care or placebo, treatment effects were larger in high-risk-of-bias trials (n=35) than low/unclear-risk-of-bias trials (n=22). In the main analysis (excluding high-risk-of-bias trials), triamcinolone had the highest probabilities of reaching the MID at weeks 2-6 (75.3% and 90%, respectively) with corresponding SMDs of -0.48 (95%CrI,-0.85 to -0.10) and -0.53 (95%CrI,-0.79 to -0.27) compared to placebo. Tr14/Ze14 homeopathic product showed therapeutic potential at week 6 compared to placebo (SMD:-0.42, 95%CrI,-0.71 to -0.11, 63.5% probability of reaching the MID). Hyaluronic acid had higher risk of dropouts due to adverse events (OR:2.01, 95%CrI,1.08 to 3.77) and serious adverse events (OR:1.86, 95%CrI,1.16 to 3.03) than placebo.CONCLUSIONTriamcinolone had the highest probabilities to have a treatment effect beyond the MID at weeks 2-6. Large RCTs with lower risk of bias do not support the notion that 16 other intra-articular interventions assessed improve pain or function beyond placebo effects in knee or hip OA. Lack of evidence of long-term effectiveness underscores the need for further research beyond 24-52 weeks.
{"title":"Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomised trials: a systematic review and network meta-analysis.","authors":"Tiago V Pereira,Pakeezah Saadat,Pavlos Bobos,Samir M Iskander,Nicolas S Bodmer,Martina Rudnicki,Henry Dan Kiyomoto,Thais Montezuma,Matheus O Almeida,Rishi Bansal,Pai-Shan Cheng,Jason W Busse,Alex J Sutton,Peter Tugwell,Gillian A Hawker,Peter Jüni,Bruno R da Costa","doi":"10.1016/j.joca.2024.08.014","DOIUrl":"https://doi.org/10.1016/j.joca.2024.08.014","url":null,"abstract":"OBJECTIVETo quantify the effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis through a systematic review and Bayesian random-effects network meta-analysis.DESIGNWe searched CENTRAL and regulatory agency websites (inception-2023) for large, English-language, randomised controlled trials (RCTs) (≥100 patients/group) examining any intra-articular intervention.PRIMARY OUTCOMEpain intensity.SECONDARY OUTCOMESphysical function and safety outcomes. Pain and function outcomes were analyzed at 2,6,12,24, and 52 weeks post-randomization, and presented as standardized mean differences (SMDs) (95% credible intervals, 95%CrI). The prespecified minimal clinically important between-group difference (MID) was -0.37 SMD. Safety outcomes were presented as odds ratios (OR) (95%CrI).FINDINGSAmong 57 RCTs (22,795 participants) examining 18 intra-articular interventions, usual care or placebo, treatment effects were larger in high-risk-of-bias trials (n=35) than low/unclear-risk-of-bias trials (n=22). In the main analysis (excluding high-risk-of-bias trials), triamcinolone had the highest probabilities of reaching the MID at weeks 2-6 (75.3% and 90%, respectively) with corresponding SMDs of -0.48 (95%CrI,-0.85 to -0.10) and -0.53 (95%CrI,-0.79 to -0.27) compared to placebo. Tr14/Ze14 homeopathic product showed therapeutic potential at week 6 compared to placebo (SMD:-0.42, 95%CrI,-0.71 to -0.11, 63.5% probability of reaching the MID). Hyaluronic acid had higher risk of dropouts due to adverse events (OR:2.01, 95%CrI,1.08 to 3.77) and serious adverse events (OR:1.86, 95%CrI,1.16 to 3.03) than placebo.CONCLUSIONTriamcinolone had the highest probabilities to have a treatment effect beyond the MID at weeks 2-6. Large RCTs with lower risk of bias do not support the notion that 16 other intra-articular interventions assessed improve pain or function beyond placebo effects in knee or hip OA. Lack of evidence of long-term effectiveness underscores the need for further research beyond 24-52 weeks.","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"1 1","pages":""},"PeriodicalIF":7.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142231325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-04DOI: 10.1016/j.joca.2024.08.013
Pakeezah Saadat, Tiago V. Pereira, Rahim Lalji, Henry D. Kiyomoto, Nicolas S. Bodmer, Pavlos Bobos, Samir Iskander, Areti-Angeliki Veroniki, Gillian A. Hawker, Alex J. Sutton, Peter Jüni, Bruno R. da Costa
To rank commonly used patient-reported outcome measures (PROMs) for assessing pain in osteoarthritis trials according to their assay sensitivity, defined as the ability of a PROM to distinguish an effective from a less effective intervention or placebo, proposing a hierarchy for PROM selection in trials and data-extraction in meta-analyses. Analysis of trials with placebo, sham, or non-intervention control that included ≥100 patients per arm with knee/hip osteoarthritis, reporting treatment effects on ≥2 pain PROMs. Treatment effects from all PROMs were standardized on a 0–100 scale. Negative mean differences indicated a larger effect of the experimental treatment compared to control. We ranked PROMs by assay sensitivity using a Bayesian multi-outcome synthesis random-effects model. 135 trials comprising 57,141 participants were included. The ranking of PROMs from highest to lowest assay sensitivity was as follows: pain overall, pain on stairs, pain at night, pain on walking, pain at rest, WOMAC pain, WOMAC global, Lequesne index. Pain overall, the highest-ranked PROM, had a pooled mean difference of −6.96 (95%CrI −7.94, −6.02), while WOMAC pain, the most reported PROM in our study, had a pooled mean difference of −4.90 (95%CrI −5.55, −4.26). The pooled ratio of mean differences between pain overall and WOMAC pain was 1.42 (95%CrI 1.30, 1.55), representing a 42% larger effect size with pain overall. Pain overall has better assay sensitivity than other pain PROMs. Investigators should consider the hierarchy proposed in this study to guide PROM selection in osteoarthritis clinical trials and data extraction in osteoarthritis meta-analyses.
{"title":"Evidence-based hierarchy of pain outcome measures for osteoarthritis clinical trials and meta-analyses","authors":"Pakeezah Saadat, Tiago V. Pereira, Rahim Lalji, Henry D. Kiyomoto, Nicolas S. Bodmer, Pavlos Bobos, Samir Iskander, Areti-Angeliki Veroniki, Gillian A. Hawker, Alex J. Sutton, Peter Jüni, Bruno R. da Costa","doi":"10.1016/j.joca.2024.08.013","DOIUrl":"https://doi.org/10.1016/j.joca.2024.08.013","url":null,"abstract":"To rank commonly used patient-reported outcome measures (PROMs) for assessing pain in osteoarthritis trials according to their assay sensitivity, defined as the ability of a PROM to distinguish an effective from a less effective intervention or placebo, proposing a hierarchy for PROM selection in trials and data-extraction in meta-analyses. Analysis of trials with placebo, sham, or non-intervention control that included ≥100 patients per arm with knee/hip osteoarthritis, reporting treatment effects on ≥2 pain PROMs. Treatment effects from all PROMs were standardized on a 0–100 scale. Negative mean differences indicated a larger effect of the experimental treatment compared to control. We ranked PROMs by assay sensitivity using a Bayesian multi-outcome synthesis random-effects model. 135 trials comprising 57,141 participants were included. The ranking of PROMs from highest to lowest assay sensitivity was as follows: pain overall, pain on stairs, pain at night, pain on walking, pain at rest, WOMAC pain, WOMAC global, Lequesne index. Pain overall, the highest-ranked PROM, had a pooled mean difference of −6.96 (95%CrI −7.94, −6.02), while WOMAC pain, the most reported PROM in our study, had a pooled mean difference of −4.90 (95%CrI −5.55, −4.26). The pooled ratio of mean differences between pain overall and WOMAC pain was 1.42 (95%CrI 1.30, 1.55), representing a 42% larger effect size with pain overall. Pain overall has better assay sensitivity than other pain PROMs. Investigators should consider the hierarchy proposed in this study to guide PROM selection in osteoarthritis clinical trials and data extraction in osteoarthritis meta-analyses.","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"44 1","pages":""},"PeriodicalIF":7.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142142422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-03DOI: 10.1016/j.joca.2024.08.011
Ali Guermazi
{"title":"Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough!","authors":"Ali Guermazi","doi":"10.1016/j.joca.2024.08.011","DOIUrl":"10.1016/j.joca.2024.08.011","url":null,"abstract":"","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1518-1521"},"PeriodicalIF":7.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-02DOI: 10.1016/j.joca.2024.08.012
Arashi Shahid, Aricia Jieqi Thirumaran, Robin Christensen, Venkatesha Venkatesha, Marius Henriksen, Jocelyn L Bowden, David J Hunter
Objective: To ascertain the comparative effectiveness of weight-loss strategies for osteoarthritis (OA) to develop rational treatment algorithms aimed at improving OA-related symptoms in overweight/obese individuals.
Design: Medline, Embase, CINAHL, Scopus, and Web of Science were searched from inception to June 2023 for observational studies and randomized trials. Network meta-analyses were performed using a frequentist approach. Effect sizes for pain and function were computed as standardized mean differences, while change in body weight was computed as mean differences.
Results: 13 RCTs on knee OA (KOA) (2800 participants) with 7 interventions: diet (D); exercise (E); diet and exercise (DE); pharmacological (L); psychological (P); psychological, diet, and exercise (PDE); and Mediterranean diets (M) were networked. For weight change (kg), all interventions significantly outperformed control comparators, with effect sizes ranging from -11.2 (95% CI, -16.0, -6.5 kg) for the most effective approach (PDE) to -4.7 (95% CI, -6.7, -2.7 kg) for the least effective approach (DE). In terms of pain (0-20 scale), only DE outperformed control comparators (-2.2, 95% CI: -4.1, -0.21), whereas PDE was not superior to control comparators (-3.9, 95% CI: -8.4, 0.5) in improving the pain. Regardless of the chosen intervention, prediction intervals from meta-regression analysis indicate that significant pain relief may be anticipated when patients achieve at least a weight reduction of 7%.
Conclusions: PDE and DE interventions may offer the most effective approach for weight loss, potentially leading to improvements in pain and physical function among overweight/obese individuals with KOA if they achieve more than 7% weight loss.
目的:确定减肥策略对骨关节炎(OA)的比较效果:确定减肥策略对骨关节炎(OA)的比较效果,以制定合理的治疗方案,改善超重/肥胖者的 OA 相关症状:设计:检索了 Medline、Embase、CINAHL、Scopus 和 Web of Science 从开始到 2023 年 6 月的观察性研究和随机试验。采用频数主义方法进行网络荟萃分析。疼痛和功能的效应大小按标准化平均差(SMD)计算,体重变化按平均差计算:结果:13 项关于膝关节 OA(KOA)的 RCT(2,800 名参与者)与 7 项干预措施进行了联网:饮食(D);运动(E);饮食和运动(DE);药物(L);心理(P);心理、饮食和运动(PDE);地中海饮食(M)。就体重变化(公斤)而言,所有干预措施的效果都明显优于对照组,效果大小从最有效方法(PDE)的-11.2(95% CI,-16.0,-6.5公斤)到最无效方法(DE)的-4.7(95% CI,-6.7,-2.7公斤)不等。在疼痛(0-20 级)方面,只有 DE 的效果优于对照组比较者(-2.2,95% CI:-4.1,-0.21),而 PDE 在改善疼痛方面并不优于对照组比较者(-3.9,95% CI:-8.4,0.5)。无论选择哪种干预措施,元回归分析得出的预测区间表明,当患者体重至少减轻 7% 时,疼痛可望得到明显缓解:PDE和DE干预可能是最有效的减肥方法,如果体重减轻7%以上,KOA超重/肥胖患者的疼痛和身体功能可能会得到改善。
{"title":"Comparison of weight loss interventions in overweight and obese adults with knee osteoarthritis: A systematic review and network meta-analysis of randomized trials.","authors":"Arashi Shahid, Aricia Jieqi Thirumaran, Robin Christensen, Venkatesha Venkatesha, Marius Henriksen, Jocelyn L Bowden, David J Hunter","doi":"10.1016/j.joca.2024.08.012","DOIUrl":"10.1016/j.joca.2024.08.012","url":null,"abstract":"<p><strong>Objective: </strong>To ascertain the comparative effectiveness of weight-loss strategies for osteoarthritis (OA) to develop rational treatment algorithms aimed at improving OA-related symptoms in overweight/obese individuals.</p><p><strong>Design: </strong>Medline, Embase, CINAHL, Scopus, and Web of Science were searched from inception to June 2023 for observational studies and randomized trials. Network meta-analyses were performed using a frequentist approach. Effect sizes for pain and function were computed as standardized mean differences, while change in body weight was computed as mean differences.</p><p><strong>Results: </strong>13 RCTs on knee OA (KOA) (2800 participants) with 7 interventions: diet (D); exercise (E); diet and exercise (DE); pharmacological (L); psychological (P); psychological, diet, and exercise (PDE); and Mediterranean diets (M) were networked. For weight change (kg), all interventions significantly outperformed control comparators, with effect sizes ranging from -11.2 (95% CI, -16.0, -6.5 kg) for the most effective approach (PDE) to -4.7 (95% CI, -6.7, -2.7 kg) for the least effective approach (DE). In terms of pain (0-20 scale), only DE outperformed control comparators (-2.2, 95% CI: -4.1, -0.21), whereas PDE was not superior to control comparators (-3.9, 95% CI: -8.4, 0.5) in improving the pain. Regardless of the chosen intervention, prediction intervals from meta-regression analysis indicate that significant pain relief may be anticipated when patients achieve at least a weight reduction of 7%.</p><p><strong>Conclusions: </strong>PDE and DE interventions may offer the most effective approach for weight loss, potentially leading to improvements in pain and physical function among overweight/obese individuals with KOA if they achieve more than 7% weight loss.</p>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1016/j.joca.2024.08.010
MA Holden , M. Murphy , J. Simkins , MJ Thomas , L. Huckfield , JG Quicke , N. Halliday , FN Birrell , B. Borrelli , MJ Callaghan , K. Dziedzic , D. Felson , NE Foster , C. Ingram , C. Jinks , S. Jowett , E. Nicholls , G. Peat
Objective
To identify and synthesise the content of knee bracing interventions in randomised controlled trials (RCTs) of knee osteoarthritis (OA).
Design
In this scoping review, three electronic databases (PubMed, Web of Science, Cochrane) were searched up to 10th June 2024. Nineteen previous systematic reviews of knee bracing for knee OA and four recent international clinical practice guidelines were also hand searched. Identified studies were screened for eligibility by two independent reviewers. Information on bracing interventions was extracted from included RCT reports, informed by Template for Intervention Description and Replication (TIDieR) guidelines. Data were synthesised narratively.
Results
Thirty-one RCTs testing 47 different bracing interventions were included. Braces were broadly grouped as valgus/varus, patellofemoral, sleeve, neutral hinged, or control/placebo knee braces. Brace manufacturer and models varied, as did amount of recommended brace use. Only three interventions specifically targeted brace adherence. Information on brace providers, setting, number of treatment sessions, and intervention modification over time was poorly reported. Adherence to brace use was described for 32 (68%) interventions, most commonly via self-report. Several mechanisms of action for knee braces were proposed, broadly grouped as biomechanical, neuromuscular, and psychological.
Conclusions
Many different knee brace interventions have been tested for knee OA, with several proposed mechanisms of action, a lack of focus on adherence, and a lack of full reporting. These issues may be contributing to the heterogeneous findings and inconsistent guideline recommendations about the clinical effectiveness of knee bracing for knee OA to date.
目的确定并综合膝关节骨性关节炎(OA)随机对照试验(RCT)中膝关节支撑干预措施的内容:在此次范围界定综述中,检索了截至 2024 年 6 月 10 日的三个电子数据库(PubMed、Web of Science 和 Cochrane)。此外,还人工检索了之前关于膝关节支撑治疗膝关节 OA 的 19 篇系统性综述以及最近的 4 份国际临床实践指南。由两名独立审查员对确定的研究进行资格筛选。根据干预措施描述与复制模板(Template for Intervention Description and Replication,TIDieR)指南,从纳入的 RCT 报告中提取有关支撑干预措施的信息。对数据进行综合叙述:结果:共纳入了 31 项测试 47 种不同矫治干预措施的 RCT。支具大致分为外翻/内翻、髌股关节、套筒、中性铰链或对照/安慰剂膝关节支具。护具制造商和型号各不相同,推荐使用的护具数量也不尽相同。只有三项干预措施专门针对支架的依从性。有关支具提供者、环境、治疗次数以及干预措施随时间推移而改变的信息报告很少。有 32 项(68%)干预措施介绍了支架使用的依从性,最常见的是通过自我报告。研究人员提出了膝部支撑的几种作用机制,大致分为生物力学、神经肌肉和心理学三类:结论:针对膝关节 OA 测试了许多不同的膝关节护具干预措施,提出了几种作用机制,但缺乏对依从性的关注,也缺乏全面的报告。这些问题可能是导致迄今为止关于膝关节支撑治疗膝关节OA临床效果的研究结果不一和指南建议不一致的原因。
{"title":"Knee braces for knee osteoarthritis: A scoping review and narrative synthesis of interventions in randomised controlled trials","authors":"MA Holden , M. Murphy , J. Simkins , MJ Thomas , L. Huckfield , JG Quicke , N. Halliday , FN Birrell , B. Borrelli , MJ Callaghan , K. Dziedzic , D. Felson , NE Foster , C. Ingram , C. Jinks , S. Jowett , E. Nicholls , G. Peat","doi":"10.1016/j.joca.2024.08.010","DOIUrl":"10.1016/j.joca.2024.08.010","url":null,"abstract":"<div><h3>Objective</h3><div>To identify and synthesise the content of knee bracing interventions in randomised controlled trials (RCTs) of knee osteoarthritis (OA).</div></div><div><h3>Design</h3><div>In this scoping review, three electronic databases (PubMed, Web of Science, Cochrane) were searched up to 10th June 2024. Nineteen previous systematic reviews of knee bracing for knee OA and four recent international clinical practice guidelines were also hand searched. Identified studies were screened for eligibility by two independent reviewers. Information on bracing interventions was extracted from included RCT reports, informed by Template for Intervention Description and Replication (TIDieR) guidelines. Data were synthesised narratively.</div></div><div><h3>Results</h3><div>Thirty-one RCTs testing 47 different bracing interventions were included. Braces were broadly grouped as valgus/varus, patellofemoral, sleeve, neutral hinged, or control/placebo knee braces. Brace manufacturer and models varied, as did amount of recommended brace use. Only three interventions specifically targeted brace adherence. Information on brace providers, setting, number of treatment sessions, and intervention modification over time was poorly reported. Adherence to brace use was described for 32 (68%) interventions, most commonly via self-report. Several mechanisms of action for knee braces were proposed, broadly grouped as biomechanical, neuromuscular, and psychological.</div></div><div><h3>Conclusions</h3><div>Many different knee brace interventions have been tested for knee OA, with several proposed mechanisms of action, a lack of focus on adherence, and a lack of full reporting. These issues may be contributing to the heterogeneous findings and inconsistent guideline recommendations about the clinical effectiveness of knee bracing for knee OA to date.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 11","pages":"Pages 1371-1396"},"PeriodicalIF":7.2,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1016/j.joca.2024.08.009
Yeon Lee, Hyo-Eun Kim, Ji-Sun Kwak, Chul-Seung Park, Jang-Soo Chun
Objective
AMP-activated protein kinase (AMPK) dysregulation is implicated in osteoarthritis (OA), but the mechanisms underlying this dysregulation remain unclear. We investigated the role of cereblon, a substrate-recognition protein within the E3-ligase ubiquitin complex, in AMPK dysregulation and OA pathogenesis.
Methods
Cereblon expression was examined in human (n = 5) and mouse (n = 10) OA cartilage. The role of cereblon was investigated through its adenoviral overexpression (n = 10) or knockout (KO, n = 15) in the destabilization of the medial meniscus (DMM)-operated mice. The therapeutic potentials of the chemical cereblon degrader, TD-165, and the AMPK activator, metformin, were assessed through intra-articular (IA) injection to mice (n = 15).
Results
Immunostaining revealed that cereblon is upregulated in human and mouse OA cartilage. In DMM model mice, cartilage destruction was exacerbated by overexpression of cereblon in mouse joint tissues (OARSI grade; 1.11 [95% CI: 0.50 to 2.75]), but inhibited in global (−2.50 [95% CI: −3.00 to −1.17]) and chondrocyte-specific (−2.17 [95% CI: −3.14 to −1.06]) cereblon KO mice. The inhibitory effects were more pronounced in mice fed a high-fat diet compared to a regular diet. The degradation of cereblon through IA injection of TD-165 inhibited OA cartilage destruction (−2.47 [95% CI: −3.22 to −1.56]). Mechanistically, cereblon exerts its catabolic effects by negatively modulating AMPK activity within chondrocytes. Consistently, activation of AMPK by IA injection of metformin inhibited posttraumatic OA cartilage destruction (−1.20 ([95% CI: −1.89 to −0.45]).
Conclusions
The cereblon-AMPK axis acts as a catabolic regulator of OA pathogenesis and seems to be a promising therapeutic target in animal models of OA.
{"title":"The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis","authors":"Yeon Lee, Hyo-Eun Kim, Ji-Sun Kwak, Chul-Seung Park, Jang-Soo Chun","doi":"10.1016/j.joca.2024.08.009","DOIUrl":"10.1016/j.joca.2024.08.009","url":null,"abstract":"<div><h3>Objective</h3><div>AMP-activated protein kinase (AMPK) dysregulation is implicated in osteoarthritis (OA), but the mechanisms underlying this dysregulation remain unclear. We investigated the role of cereblon, a substrate-recognition protein within the E3-ligase ubiquitin complex, in AMPK dysregulation and OA pathogenesis.</div></div><div><h3>Methods</h3><div>Cereblon expression was examined in human (n = 5) and mouse (n = 10) OA cartilage. The role of cereblon was investigated through its adenoviral overexpression (n = 10) or knockout (KO, n = 15) in the destabilization of the medial meniscus (DMM)-operated mice. The therapeutic potentials of the chemical cereblon degrader, TD-165, and the AMPK activator, metformin, were assessed through intra-articular (IA) injection to mice (n = 15).</div></div><div><h3>Results</h3><div>Immunostaining revealed that cereblon is upregulated in human and mouse OA cartilage. In DMM model mice, cartilage destruction was exacerbated by overexpression of cereblon in mouse joint tissues (OARSI grade; 1.11 [95% CI: 0.50 to 2.75]), but inhibited in global (−2.50 [95% CI: −3.00 to −1.17]) and chondrocyte-specific (−2.17 [95% CI: −3.14 to −1.06]) cereblon KO mice. The inhibitory effects were more pronounced in mice fed a high-fat diet compared to a regular diet. The degradation of cereblon through IA injection of TD-165 inhibited OA cartilage destruction (−2.47 [95% CI: −3.22 to −1.56]). Mechanistically, cereblon exerts its catabolic effects by negatively modulating AMPK activity within chondrocytes. Consistently, activation of AMPK by IA injection of metformin inhibited posttraumatic OA cartilage destruction (−1.20 ([95% CI: −1.89 to −0.45]).</div></div><div><h3>Conclusions</h3><div>The cereblon-AMPK axis acts as a catabolic regulator of OA pathogenesis and seems to be a promising therapeutic target in animal models of OA.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1579-1590"},"PeriodicalIF":7.2,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-28DOI: 10.1016/j.joca.2024.08.007
Yuanfei Fu , Zhiming Lan , Ning Li , Lianping Xing , Luying Yuan , Juyi Lai , Hualong Feng , Lin Cong , Yongjun Wang , Shenghua He , Qianqian Liang
Objective
To investigate the role of the paravertebral lymphatic system in the nucleus pulposus herniation (NPH) resorption and the inflammation regression.
Design
Clinical specimens (n = 10) from patients with lumbar disc herniation (LDH) were collected, C57BL/6 (n = 84) and conditional Vegfr3 knockout mice (n = 14) were used. Immunofluorescence staining detected lymphatic vessels (LVs) and NP cells. Near-infrared imaging assessed lymphatic drainage function, and Alcian Blue/Orange determined inflammation.
Results
Lymphangiogenesis was observed in the herniated NP of patients with LDH, and the proportion of capillary LVs was higher than that of collecting LVs (mean 68.2% [95% confidence interval: 59.4, 77.1]). In NPH mice, NP cells were detected in paravertebral tissue (38.6 [32.0, 45.2]) and draining lymph nodes (dLN) at 4 h (76.9 [54.9, 98.8]). A significant increase of NP cells in dLNs was observed at 24 h (157.1 [113.7, 200.6]). Most of the herniated NP cells were cleared in paravertebral tissue after 1 week (7.5 [4.4, 10.6]), but disc inflammation peaked at 1 week (19.9% [14.7, 25.1]), along with persistent lymphangiogenesis (9.5 [7.2, 11.8]). However, conditional Vegfr3 knockout mice exhibited impaired lymphangiogenesis (5.7 [4.4, 7.0]) and herniated NP cell clearance (6.1 [1.8, 10.5]) during NPH, leading to exacerbated disc inflammation (23.7% [19.3, 28.2]).
Conclusion
The paravertebral lymphatic system is involved in the NPH resorption and inflammation regression. Promoting lymphangiogenesis may be a novel strategy for facilitating NPH resorption and inflammation regression in patients with LDH.
{"title":"The paravertebral lymphatic system is involved in the resorption of the herniated nucleus pulposus and the regression of inflammation associated with disc herniation","authors":"Yuanfei Fu , Zhiming Lan , Ning Li , Lianping Xing , Luying Yuan , Juyi Lai , Hualong Feng , Lin Cong , Yongjun Wang , Shenghua He , Qianqian Liang","doi":"10.1016/j.joca.2024.08.007","DOIUrl":"10.1016/j.joca.2024.08.007","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the role of the paravertebral lymphatic system in the nucleus pulposus herniation (NPH) resorption and the inflammation regression.</div></div><div><h3>Design</h3><div>Clinical specimens (n = 10) from patients with lumbar disc herniation (LDH) were collected, C57BL/6 (n = 84) and conditional Vegfr3 knockout mice (n = 14) were used. Immunofluorescence staining detected lymphatic vessels (LVs) and NP cells. Near-infrared imaging assessed lymphatic drainage function, and Alcian Blue/Orange determined inflammation.</div></div><div><h3>Results</h3><div>Lymphangiogenesis was observed in the herniated NP of patients with LDH, and the proportion of capillary LVs was higher than that of collecting LVs (mean 68.2% [95% confidence interval: 59.4, 77.1]). In NPH mice, NP cells were detected in paravertebral tissue (38.6 [32.0, 45.2]) and draining lymph nodes (dLN) at 4 h (76.9 [54.9, 98.8]). A significant increase of NP cells in dLNs was observed at 24 h (157.1 [113.7, 200.6]). Most of the herniated NP cells were cleared in paravertebral tissue after 1 week (7.5 [4.4, 10.6]), but disc inflammation peaked at 1 week (19.9% [14.7, 25.1]), along with persistent lymphangiogenesis (9.5 [7.2, 11.8]). However, conditional Vegfr3 knockout mice exhibited impaired lymphangiogenesis (5.7 [4.4, 7.0]) and herniated NP cell clearance (6.1 [1.8, 10.5]) during NPH, leading to exacerbated disc inflammation (23.7% [19.3, 28.2]).</div></div><div><h3>Conclusion</h3><div>The paravertebral lymphatic system is involved in the NPH resorption and inflammation regression. Promoting lymphangiogenesis may be a novel strategy for facilitating NPH resorption and inflammation regression in patients with LDH.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1566-1578"},"PeriodicalIF":7.2,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}